SynAct Pharma
17.72 SEK
+1.14 %
Less than 1K followers
SYNACT
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for SynAct Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -24.3 | -20.8 | -90.0 | -28.1 | -30.4 | -35.4 | ||
| EBIT | -24.3 | -20.8 | -90.0 | -28.1 | -30.4 | -35.4 | -22.7 | -116.5 |
| EBIT-% | ||||||||
| Profit before taxes | -24.7 | -20.3 | -90.8 | -30.3 | -30.1 | -35.7 | -22.9 | -119.0 |
| Net income | -20.5 | -18.4 | -82.4 | -24.7 | -27.5 | -35.7 | -22.9 | -110.8 |